OSCR

Characterization of a distinct form of vimentin in the neurodegenerative brain.

Overview

Authors: Abdulkhalek Dakhel1, Johanna Vestin1, Vilmantas Giedraitis1, Dag Nyholm2, Martin Ingelsson1,3,4, Anna Erlandsson1
  1. Department of Public Health and Caring Sciences, Molecular Geriatrics, Uppsala University, Uppsala, Sweden
  2. Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden
  3. University Health Network, Krembil Brain Institute, Toronto, ON Canada
  4. Tanz Centre for Research in Neurodegenerative Diseases, Departments of Medicine and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON Canada
Institutions: Uppsala University (Sweden); University of Toronto (Canada); Krembil Brain Institute (Canada)
Journal: Acta neuropathologica communications, volume 14, issue 1, article 111
Dates: received 10 March 2026; accepted 12 May 2026; published online 22 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1186/s40478-026-02324-9 · PMID 42174650 · PMCID PMC13196128 · OpenAlex W7162092264
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), Alzheimer's / dementia (population), Parkinson's (population), cellular / molecular (subfield)
Methods: Spectral & time-frequency, Statistics
Keywords: Vimentin, Astrocytes, Alzheimer's disease, Parkinson’s disease, Amyloid-beta, Alpha-synuclein
MeSH: Alzheimer Disease*, Brain*, Parkinson Disease*, Vimentin*, Aged, Aged, 80 and over, alpha-Synuclein, Amyloid beta-Peptides, Animals, Astrocytes, Female, Humans, Male (* major topic)
Topic: Skin and Cellular Biology Research (Cell Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 53 references in the paper
Research resources: RRID:CVCL_JL74

Abstract

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are characterized by brain accumulation of aggregated proteins, leading to neuronal and glial dysfunction. Compelling data indicate that changes in vimentin expression, structure, and localization reflect alterations in cellular homeostasis and may correlate with disease progression. Yet, the involvement of abnormal vimentin in AD and PD remains unclear. Here, we have thoroughly characterized the distribution of modified, disease-associated vimentin in the AD and PD brain parenchyma, as well as in cerebrospinal fluid (CSF), hiPSC-derived astrocytes and organoids. For this purpose, we used the form-specific vimentin antibody [84-1], originally generated to recognize abnormal vimentin on the surface of sarcoma cells. The 84-1 vimentin reactivity pattern was characterized through immunohistochemistry and proximity ligation assay. Moreover, proteomic analysis, Western blot, and ELISA were performed to quantify 84-1 vimentin levels and gain insights into its molecular features. Our data demonstrate that 84-1 can identify a distinct population of vimentin in the human brain that shows low affinity to commonly used vimentin antibodies. The 84-1 vimentin is enriched in disease conditions and forms distinct deposits in the affected regions of the AD and PD brain, often colocalizing with pathological protein aggregates. Interestingly, the 84-1 vimentin pool consists mainly of cleaved proteoforms and reduction-resistant aggregates. Moreover, 84-1 vimentin levels are elevated in the CSF of AD and PD patients as well as in the culture medium of human astrocytes exposed to αSyn or Aβ fibrils. Taken together, our data highlights the importance of modified vimentin in neurodegeneration and presents 84-1 vimentin as a potential biomarker and future treatment target for AD and PD.

Supplementary Information: The online version contains supplementary material available at 10.1186/s40478-026-02324-9.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

All generated data are available from the corresponding author on reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Funding: added Stiftelsen Forska Utan Djurförsök: F2022, F2022-0004; Gun och Bertil Stohnes Stiftelse; Karolinska Institutet; Vetenskapsrådet: 2024-03586; Åhlén-stiftelsen; Uppsala Universitet; Parkinsonfonden: 1476/23

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 6 keywords, 13 MeSH terms, 52 references, 1 RRID.

Cite

This paper

Dakhel, A., Vestin, J., Giedraitis, V., Nyholm, D., Ingelsson, M., & Erlandsson, A. (2026). Characterization of a distinct form of vimentin in the neurodegenerative brain. Acta neuropathologica communications, 14(1), 111. https://doi.org/10.1186/s40478-026-02324-9

BibTeX

@article{dakhel2026characterization,
author = {Dakhel, Abdulkhalek and Vestin, Johanna and Giedraitis, Vilmantas and Nyholm, Dag and Ingelsson, Martin and Erlandsson, Anna},
title = {{Characterization of a distinct form of vimentin in the neurodegenerative brain}},
journal = {Acta neuropathologica communications},
year = {2026},
month = may,
volume = {14},
number = {1},
pages = {111},
publisher = {BMC},
issn = {2051-5960},
doi = {10.1186/s40478-026-02324-9},
url = {https://doi.org/10.1186/s40478-026-02324-9},
pmid = {42174650},
pmcid = {PMC13196128}
}

RIS

TY - JOUR
AU - Dakhel, Abdulkhalek
AU - Vestin, Johanna
AU - Giedraitis, Vilmantas
AU - Nyholm, Dag
AU - Ingelsson, Martin
AU - Erlandsson, Anna
TI - Characterization of a distinct form of vimentin in the neurodegenerative brain
T2 - Acta neuropathologica communications
J2 - Acta Neuropathol Commun
PY - 2026
DA - 2026/05/22
VL - 14
IS - 1
SP - 111
SN - 2051-5960
PB - BMC
DO - 10.1186/s40478-026-02324-9
UR - https://doi.org/10.1186/s40478-026-02324-9
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s40478-026-02324-9",
"type": "article-journal",
"title": "Characterization of a distinct form of vimentin in the neurodegenerative brain",
"container-title": "Acta neuropathologica communications",
"author": [
{
"family": "Dakhel",
"given": "Abdulkhalek"
},
{
"family": "Vestin",
"given": "Johanna"
},
{
"family": "Giedraitis",
"given": "Vilmantas"
},
{
"family": "Nyholm",
"given": "Dag"
},
{
"family": "Ingelsson",
"given": "Martin"
},
{
"family": "Erlandsson",
"given": "Anna"
}
],
"container-title-short": "Acta Neuropathol Commun",
"volume": "14",
"issue": "1",
"page": "111",
"DOI": "10.1186/s40478-026-02324-9",
"PMID": "42174650",
"PMCID": "PMC13196128",
"ISSN": "2051-5960",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s40478-026-02324-9",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
22
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12974-025-03433-3
A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis.
Journal: Journal of neuroinflammation
In common: Alzheimer's / dementia, cellular / molecular, 3 references
[2] doi:10.1038/s41467-026-75895-9
Distinct Filament Conformation for Receptor-Bound Amyloid-β from Alzheimer's Disease Brain.
Journal: Nature communications
In common: Alzheimer's / dementia, cellular / molecular, 3 references
[3] doi:10.3389/fimmu.2026.1845312
Prenatal immune activation and adult Poly(I:C) re-challenge promote neuroimmune priming and AD-related behavioural, cellular and molecular alterations in wild-type mice.
Journal: Frontiers in immunology
In common: Alzheimer's / dementia, 3 references
[4] doi:10.1126/sciadv.adq2742
Vimentin network dysregulation mediates neurite deficits in <i>SNCA</i> duplication Parkinson's patient-derived midbrain neurons.
Journal: Science advances
In common: Parkinson's, 2 references
[5] doi:10.1126/sciadv.adp8504 [code]
Astrocytic RNA editing regulates the host immune response to alpha-synuclein.
Journal: Science advances
In common: Parkinson's, cellular / molecular, 2 references
[6] doi:10.3389/fnins.2022.824888
Microglia and Astrocyte Function and Communication: What Do We Know in Humans?
Journal: Frontiers in neuroscience
In common: Alzheimer's / dementia, cellular / molecular, 2 references
[7] doi:10.1038/s43587-025-00810-8
Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ<sub>42</sub>/Aβ<sub>40</sub> ratios, neurofilament light and tau in Alzheimer's disease model mice.
Journal: Nature aging
In common: Alzheimer's / dementia, 2 references
[8] doi:10.1186/s41065-025-00491-8
TIMP1 promotes microglia M2 polarization through MAPK pathway to ameliorate early brain injury after ischemia.
Journal: Hereditas
In common: cellular / molecular, 2 references
[9] doi:10.1186/s13195-024-01471-2 [code]
Experimental colitis in young Tg2576 mice accelerates the onset of an Alzheimer's-like clinical phenotype.
Journal: Alzheimer's research & therapy
In common: Alzheimer's / dementia, 2 references
[10] doi:10.1016/j.isci.2026.115819
Exposure to fibrillar proteins leads to widespread infiltration but only mild tau pathology in cortical organoids.
Journal: iScience
In common: Alzheimer's / dementia, cellular / molecular, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.